『CDC Warns of Marburg Virus Outbreak in Ethiopia and Highlights Health Risks for Travelers to Haiti and India』のカバーアート

CDC Warns of Marburg Virus Outbreak in Ethiopia and Highlights Health Risks for Travelers to Haiti and India

CDC Warns of Marburg Virus Outbreak in Ethiopia and Highlights Health Risks for Travelers to Haiti and India

無料で聴く

ポッドキャストの詳細を見る

このコンテンツについて

Several important health alerts have emerged for the United States and Americans traveling abroad as we head into the second week of December.

The Centers for Disease Control and Prevention has issued a health advisory regarding a new outbreak of Marburg virus disease identified in Ethiopia's South Ethiopia and Sidama regions. This is the first reported outbreak of Marburg virus disease in Ethiopia. As of December third, no suspected, probable, or confirmed cases related to this outbreak have been reported in the United States or other countries. However, the CDC notes that clinicians should be aware of the potential for imported cases and should obtain detailed travel histories from patients with acute febrile illness, particularly those who have recently traveled to affected areas of Ethiopia.

Health officials are also warning Americans headed to Haiti and India to practice precautions after travelers have returned home from those countries with rabies. These travel warnings underscore the importance of seeking appropriate medical care and post-exposure prophylaxis if there is any potential exposure during travel.

On the vaccination front, King County Public Health continues to emphasize the importance of hepatitis B vaccination for newborns. Public health officials recommend that all newborns receive the hepatitis B vaccine within twenty-four hours of delivery and complete the full three to four dose series by eighteen months of age. This recommendation comes as the Advisory Committee on Immunization Practices is expected to vote on potential changes to hepatitis B birth dose recommendations at meetings scheduled for December fourth and fifth. The hepatitis B vaccine has been extensively tested for safety and efficacy, with studies showing that ninety-eight percent of healthy infants achieve full immunity after completing the full vaccine series, with protection lasting at least thirty years.

Thank you for tuning in to today's health alert update. Be sure to subscribe for the latest public health information. This has been a Quiet Please production. For more, check out quietplease.ai.

For more http://www.quietplease.ai

Get the best deals https://amzn.to/3ODvOta

This content was created in partnership and with the help of Artificial Intelligence AI
まだレビューはありません